Skip to main content
. 2019 Mar 18;7(3):48. doi: 10.3390/medsci7030048

Figure 3.

Figure 3

Complete response of a 57-year-old patient with low-grade fibromyxoid sarcoma of the lower back after 2 months of treatment with pazopanib. No malignancy was identified after debridement of the wound, indicating pathologic complete response. MRI of lumbar spine before (a) and after (b) pazopanib treatment. Red arrows indicate the location of the tumor masses.